FOIA document: In 2007, US Ambassador Ralph Boyce was pleased that Abbott withdrew life saving drugs from market in Thailand

In 2007, Thailand was involved in a dispute over the granting of compulsory licenses on medicines, including the patents used for Kaletra, an Abbott drug used in the treatment of AIDS. Kaletra is the brand name for a fixed dose combination of lopinavir and ritonavir (LPV/r) — two drugs invented at Abbott on an NIH grant. In 2007, LPV/r was the preferred combination for protease inhibitor regimes used to treat AIDS. Continue Reading

Working Document Proposed by Barbados and Bolivia

https://www.keionline.org/misc-docs/b_b_igwg/working_document_barbados_bolivia.pdf April 2008 According to resolution WHA60.30 on Public Health, Innovation and Intellectual Property, the Director-General of the WHO is asked: (4) to encourage the development of proposals for health-needs driven research and development for discussion at the Intergovernmental Working… Continue Reading

Colombian Submission to the WHO IGWG negotiation favors drug company positions on IP

By resolution WHA 59.24, the WHO’s Intergovernmental Working Group on Public Health, Innovation, and Intellectual Property (IGWG) has the goal of producing a Global Strategy and Plan of Action that will implement the CIPIH report recommendations and “secure an enhanced and sustainable basis for needs-driven, essential health research and development relevant to diseases that disproportionately affect developing countries, proposing cle Continue Reading